The U.S. Food and Drug Administration approved Tyruko, the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced that the U.S. Food and Drug Administration (FDA) has granted...
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook...
CVS Health®, announced that it has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products (an...
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced 510(k) clearance from the U.S. Food and...
